A pharmacogenomic-CAM connection in diabetes
Monday, June 29th, 2009
 Dr. Andrew Levy from Technion-Israel Institute of Technology in Haifa makes the case for a new pharmacogenomic blood test that can be used to identify diabetes patients at highest risk for cardiovascular disease.
Presently, medical costs of treating cardiovascular complications of diabetes are more than $100 billion per year in the US. (more…)
Since pre-medication isn’t widely accepted in spinal anesthesia, researchers from Saitama Medical University, in Kawagoe, Japan
 Researchers from Ain Shams University, in Cairo, Egypt
FDA is
 These are the
Meniere’s syndrome damages the balance and hearing parts of the inner ear.
 Acupuncture is often used as a treatment for dementia.
Researchers at the University of Chicago